Cargando…

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer

BACKGROUND: Alternative splicing (AS) is one of the critical post-transcriptional regulatory mechanisms of various cancers and also plays a crucial role in the development of cancers, including endometrial cancer (EC). METHODS: The splicing data and gene expression profiles of EC were obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peigen, He, Junxian, Ye, Huixia, Jiang, Senwei, Li, Yunhui, Li, Xiaomao, Wan, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272712/ https://www.ncbi.nlm.nih.gov/pubmed/32547595 http://dx.doi.org/10.3389/fgene.2020.00456

Ejemplares similares

Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Recurrence-Associated Multi-RNA Signature to Predict Disease-Free Survival for Ovarian Cancer Patients
por: Zhang, Yu, et al.
Publicado: (2020)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
por: Ruan, Tianyuan, et al.
Publicado: (2022)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Comprehensive Identification and Alternative Splicing of Microexons in Drosophila
por: Pang, Ting-Lin, et al.
Publicado: (2021)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

An Acid Response IR780-Based Targeted Nanoparticle for Intraoperative Near-Infrared Fluorescence Imaging of Ovarian Cancer
por: Song, Jiao, et al.
Publicado: (2022)

Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer
por: Zhang, He, et al.
Publicado: (2021)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2020)

Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing
por: Jiang, Senwei, et al.
Publicado: (2022)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

Comprehensive Network Analysis Reveals Alternative Splicing-Related lncRNAs in Hepatocellular Carcinoma
por: Wang, Junqing, et al.
Publicado: (2020)

Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction
por: Xu, Jie, et al.
Publicado: (2022)

Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
por: Wang, Qian, et al.
Publicado: (2019)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

Genome-Wide Analysis for the Regulation of Gene Alternative Splicing by DNA Methylation Level in Glioma and its Prognostic Implications
por: Yang, Zeyuan, et al.
Publicado: (2022)

Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer
por: Shao, Xiang-yang, et al.
Publicado: (2020)

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma
por: Wu, Zhipeng, et al.
Publicado: (2020)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients
por: Dai, Zhibing, et al.
Publicado: (2023)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer
por: Ding, Hao, et al.
Publicado: (2020)

Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
por: Pei, Li-Peng, et al.
Publicado: (2022)

Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal Cancer
por: Zong, Zhen, et al.
Publicado: (2018)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
por: Chen, Yun
Publicado: (2022)

Identification of Alternative Splicing-Related Genes CYB561 and FOLH1 in the Tumor-Immune Microenvironment for Endometrial Cancer Based on TCGA Data Analysis
por: Sun, Dan, et al.
Publicado: (2022)

Modularized Perturbation of Alternative Splicing Across Human Cancers
por: Du, Yabing, et al.
Publicado: (2019)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

A novel prognostic signature of cuproptosis-related genes and the prognostic value of FDX1 in gliomas
por: Zhu, HuaXin, et al.
Publicado: (2022)

Comprehensive Analysis of Prognostic Alternative Splicing Signature Reveals Recurrence Predictor for Papillary Thyroid Cancer
por: Liu, Mian, et al.
Publicado: (2021)

Immunological significance of alternative splicing prognostic signatures for bladder cancer
por: Li, Xinyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n1lvi90p15sd6196f79vgbmsca